Glomerular Disease (157)

A pathophysiology-based approach to the diagnosis and treatment of lupus nephritis

Insights into the epidemiology and management of lupus nephritis from the US rheumatologist’s perspective

Target validation for ANCA vasculitis: the role of compliment

Webinar: Update on randomised trials in lupus nephritis

Should aspirin be used for primary prevention of thrombotic events in patients with membranous nephropathy?

膜性肾病患者是否需要使用阿司匹林？

C3 Glomerulopathy and Post-Tranplant Recurrence

Lupus Nephritis: Current Perspectives

Glomerular diseases in the genomic era: «From risk Loci to Therapy »

Glomerular disease with idiopathic linear immunoglobulin deposition: a rose by any other name would be atypical

补体旁路途径异常相关肾病的诊断

Diagnosis of complement alternative pathway disorders

低剂量静脉滴注环磷酰胺与口服吗替麦考酚酯治疗狼疮性肾炎疗效比较

Glomerular disease with idiopathic linear immunoglobulin deposition: a rose by any other name would be atypical

The clinicopathologic characteristics and outcome of atypical anti-glomerular basement membrane nephritis

Onconephrology: Paraneoplastic Glomerular Diseases

Webinar: 狼疮性肾炎诊断和治疗的新进展

Immunosuppression in IgA Nephropathy (Ten-Minute Update Series)

Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis

The MEST score provides earlier risk prediction in lgA nephropathy

Cochrane Library: Corticosteroids for nephrotic syndrome in children

Proteinuria as a surrogate marker for renal outcome: are we there yet? (Commentary)

Identifying the ideal metric of proteinuria as a predictor of renal outcome in idiopathic glomerulonephritis

A Cross-Cultural Validation of a Quality of Life Measure Using the Simple Measure of the Impact of Lupus Erythematosus in Youngsters (SMILEY©) Among Filipino Pediatric Lupus Patients

Deleting numb from proximal tubules attenuates interstitial fibrosis by mitigating G2/M arrest

Immune Cells in Renal Fibrosis: a Role for Dendritic Cells?

ANCA-associated vasculitis and immunity

Increased serum platelet microparticle contributes to glomerular endothelial injury in diabetic nephropathy

The bumpy lumpy kidney that dumped protein: granulomatous glomerular and tubulointerstitial nephritis

Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes

Membranoproliferative glomerulonephritis with masked monotypic immunoglobulin deposits

Tubulointerstitial Inflammation in Lupus Nephritis

Angiopoietin-like 4 in nephrotic syndrome: Dr. Jekyll, Mr. Hyde and their mutant clones

Lupus glomerulonephritis: How many classes make a difference?

Postinfectious glomerulonephritis: Geographic differences

The pathology of sickle cell disease and sickle cell nephropathy

Mitochondrial damage in glomerular diseases

The Oxford classification of IgAN: Insights from the VALIGA study

There is no such thing as primary FSGS

Post-Transplant FSGS Recurrence

Preeclampsia: What the nephrologist needs to know

Microangiopathies with an emphasis on infectious etiologies

IgA nephropathy and IgA vasculitis: Don’t forget about IgA-dominant post-infectious GN

Tubulointerstitial nephritis: Infectious and noninfectious

Alport syndrome and other hereditary glomerular basement membrane nephropathies

IgA Nephropathy: What have we learned in the last 5 years?

Pediatric nephrotic syndrome in developing countries

Glomerular disease in South America: Is it similar to Africa?

Tubular crystallopathies and cast nephropathies: Don’t forget to look in the lumens

GLEPP1 controls the composition of the GBM

Serum Free Light Chains in Pre-eclampsia – a novel biomarker?

ANCA-Associated vasculitis in Northern Jutland in Denmark: Epidemiological patterns

Impact of Type of Calcineurin Inhibitor on Incidence of Post Renal Transplant Tuberculosis in India: A Tuberculosis Endemic Area

Mac-1 Deficiency Exacerbates Glomerulonephritis In Experimental Model Of Systemic Lupus Erythematosus

Patología vs Genética molecular: Redefiniendo el espectro del Síndrome de Alport

Nephrology Crossword: Genetics and glomerulopathies

Diagnosis of monoclonal gammopathy of renal significance

IgA nephropathy: What is new with the pathogenic molecule?

FSGS: 2013 An Update and what is the evidence?

IgA Nephropathy

ADPKD: Clinical Trials

Lupus Nephritis

Minimal Change Disease/FSGS

New insights into the pathogenesis of membranous nephropathy

Glomerular Diseases Causing Nephrotic Syndrome

Glomerular diseases causing glomerulonephritic syndrome

Which treatment for « idiopathic » membranous nephropathy

Membranous Glomerulopathy: Infectious and Autoimmune Etiologies

The Role of Novel Therapeutics and Biologics in the Treatment of SLE Nephritis

Childhood membranous nephropathy: where environment meets genetics

Membranous Lupus Nephropathy

PLA2R Assays in Membranous Nephropathy

When and How to Withdraw Therapy in Lupus Nephritis

Extended Spectrum Beta-Lactamase production in uropathogens isolated from hospitalized patients with chronic pyelonephritis.

Bile cast nephropathy

Immunity unmasks APOL1 in collapsing glomerulopathy

Complement-Mediated Kidney Disease: MPGN and aHUS

Spectrum of light chain-related disorders

Chemotherapy of light chain-related disorders

Pathology vs. molecular genetics: (re)defining the spectrum of Alport syndrome (Commentary)

Rare hereditary COL4A3/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis

IgA Nephropathy: The commonest pattern of glomerulonephritis in the world

Membranous Nephropathy

Management challenges in IgA nephropathy

Treatment of Lupus Nephritis: Challenges beyond the KDIGO Guidelines

Novel evidence on hepatitis C virus–associated glomerular disease

High prevalence of occult hepatitis C virus infection in patients with primary and secondary glomerular nephropathies

Management of ‘Treatment-Resistant’ Lupus Nephritis

Lupus Nephritis Management in Asia

Advances in the pathogenesis of HIV-associated kidney diseases

Treatment of lupus glomerulonephritis:

Acute & rapidly progressive glomerulonephritis

An update on the treatment of secondary glomerulonephritis

Paraproteins and the kidney: Chemotherapy in light chain-related disorders audioicon

Paraproteins and the kidney: Spectrum of light chain-related disorders audioicon

Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor–dependent idiopathic nephrotic syndrome

Antineutrophil cytoplasm antibody–associated vasculitis: recent developments

Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear